Rash from hepatitis C treatment

Cleveland Clinic Journal of Medicine

Volumn 78, Issue 7, 2011, Pages 472-474

  Tang, Derek M ^a   Ward, Lawrence ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALPHA2A; RECOMBINANT PROTEIN; RIBAVIRIN;

CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG ERUPTION; FEMALE; HUMAN; MIDDLE AGED; NOTE; RASH; RISK FACTOR;

ANTIVIRAL AGENTS; DRUG ERUPTIONS; EXANTHEMA; FEMALE; HUMANS; INTERFERON-ALPHA; MIDDLE AGED; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RIBAVIRIN; RISK FACTORS;

EID: 79960149017     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.78a.10124     Document Type: Note

References (5)

1. Dereure O, Raison-Peyron N, Larrey D, Blanc F, Guilhou JJ. Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients. Br J Dermatol 2002; 147:1142-1146.
2. Ferri C, Zignego AL, Pileri SA. Cryoglobulins. J Clin Pathol 2002; 55:4-13.
3. Faurie P, Broussolle C, Zoulim F, Trepo C, Sève P. Sarcoidosis and hepatitis C: clinical description of 11 cases. Eur J Gastroenterol Hepatol 2010; 22:967-972.
4. S hengyuan L, Songpo Y, Wen W, Wenjing T, Haitao Z, Binyou W. Hepatitis C virus and lichen planus: a reciprocal association determined by a meta-analysis. Arch Dermatol 2009; 145:1040-1047.
5. Aamir S, Ullah Z, Iqbal Z, Khan AA, Yaqub F, Malik K. Cutaneous manifestations of interferon alfa and ribavirin for hepatitis C. J Pak Assoc Dermatol 2008; 18:14-20.